View Older Stories View More Recent Stories

Jan 12, 2025 12:00PM Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
Nov 12, 2024 08:00AM Exagen Inc. Reports Third Quarter 2024 Results
Sep 4, 2024 04:05PM Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Aug 5, 2024 08:00AM Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
Aug 2, 2024 09:00AM Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Aug 1, 2024 09:00AM Exagen Inc (XGN) Appoints Jeffrey G. Black as CFO
Aug 1, 2024 09:00AM Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
Jul 22, 2024 09:00AM Exagen to Announce Second Quarter 2024 Results on August 5, 2024
May 13, 2024 08:00AM Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 6, 2024 04:05PM Exagen Announces Campaign for Lupus Awareness Month
Apr 30, 2024 04:05PM Exagen to Announce First Quarter 2024 Results on May 13, 2024
Apr 26, 2024 08:31AM Exagen Inc (XGN) Announces Board Changes
Apr 26, 2024 08:30AM Exagen Inc. Announces Changes to the Board of Directors
Apr 26, 2024 08:30AM Exagen Inc. Announces Changes to the Board of Directors
Mar 18, 2024 08:00AM Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Mar 8, 2024 09:00AM Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 8, 2024 09:00AM Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 7, 2024 04:05PM Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
Jan 30, 2024 04:05PM Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 30, 2024 04:05PM Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 8, 2024 05:18AM Exagen Inc (XGN) Reports Prelim FY23 Results, Reaffirms Guidance
Jan 7, 2024 12:00PM Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
Nov 13, 2023 04:05PM Exagen Inc. Reports Strong Third Quarter 2023 Results
Nov 9, 2023 04:05PM Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Nov 2, 2023 04:05PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Nov 2, 2023 04:05PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Oct 30, 2023 04:05PM Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
Sep 12, 2023 04:05PM Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Aug 7, 2023 08:00AM Exagen Inc. Reports Strong Second Quarter 2023 Results
Jul 26, 2023 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Jul 25, 2023 04:05PM Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
Jul 24, 2023 04:07PM Exagen Inc (XGN) Appoints Paul Kim to its Board
Jul 24, 2023 04:05PM Exagen Inc. Appoints Paul Kim to Board of Directors
May 30, 2023 09:00AM Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 15, 2023 04:05PM Exagen Inc. Reports First Quarter 2023 Results
May 1, 2023 04:05PM Exagen Announces Campaign for Lupus Awareness Month
May 1, 2023 04:05PM Exagen Announces Campaign for Lupus Awareness Month
Apr 24, 2023 04:05PM Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
Apr 24, 2023 04:05PM Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
Mar 6, 2023 04:05PM Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
Mar 6, 2023 04:05PM Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
Feb 27, 2023 09:00AM Exagen Inc. to Participate in Upcoming March Conferences
Feb 27, 2023 09:00AM Exagen Inc. to Participate in Upcoming March Conferences
Jan 30, 2023 04:05PM Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 30, 2023 04:05PM Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 23, 2023 09:00AM Exagen Inc (XGN) Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Jan 23, 2023 09:00AM Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Jan 23, 2023 09:00AM Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Nov 14, 2022 04:05PM Exagen Inc. Reports Third Quarter 2022 Results
Nov 14, 2022 04:05PM Exagen Inc. Reports Third Quarter 2022 Results
View More Recent Stories View Older Stories